A senior academic at the University of
Greenwich has been named as an eminent fellow of the UK Academy of
Pharmaceutical Sciences (APS).
Martin Snowden (pictured) is the university's Pro Vice Chancellor International as well as a Professor in Colloid and Polymer Science.
The prestigious award is given to individuals who make a significant contribution in the field of pharmaceutical science.
Professor Snowden's links with international pharmaceutical companies including Pfizer, Glaxo Smith Kline and BP, has led to research sponsorship of in excess of £4 million, supporting 25 post-doctoral researchers and 15 PhDs at the University of Greenwich.
Commenting on the award, Professor Snowden said: "It's very humbling but also very welcome to be recognised by my peers in this way.
I've worked at the University of Greenwich for some time now and have been lucky enough to collaborate with some knowledgeable and creative partners.
Pharmaceutical Science changes people's lives in an obvious and overt way: new drugs come on to the market and the quality of people's lives is prolonged and enhanced. What we do usually for the betterment of society and I am proud to work in this field."
After gaining his PhD in physical chemistry from the University of Salford, Professor Snowden became a BP post-doctoral research fellow at the University of Bristol, joining the University of Greenwich as a lecturer in physical chemistry in 1993.
He took up the post of Dean of the School of Science in September 2008 and became Pro Vice-Chancellor of the Faculty of Engineering and Science in 2012.
Professor Snowden took on the additional cross-University role of PVC International in 2014.
Vice Chancellor of the University of Greenwich, David Maguire, said: "I am extremely pleased to hear that Martin's dedicated work in pharmaceutical science has been recognised in this way.
"His longstanding commitment to excellence in teaching and research, together with his focus on improving people's lives, is a reflection of our values in Greenwich. This is great achievement."
Mark McAllister, APS Chair said: "This award is made on the recommendation of other APS members and recognises Martin as someone who has demonstrated excellence in the pharmaceutical sciences, with a particular focus on advocacy and leadership. Martin's nomination was unanimously supported by the APS Board and Advisory Board and I am delighted that Martin has been recognised in this way."
Professor Snowden formally received the award at an event prior to this year's APS PharmSci Conference, which is taking place today in Glasgow.
ENDS
